tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
US Market

Outlook Therapeutics (OTLK) Technical Analysis

Compare
1,362 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Outlook Therapeutics’s (OTLK) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Outlook Therapeutics is a Sell.
Outlook Therapeutics’s (OTLK) 20-Day exponential moving average is 1.83, while Outlook Therapeutics’s (OTLK) share price is $1.64, making it a Sell.
Outlook Therapeutics’s (OTLK) 50-Day exponential moving average is 2.28, while Outlook Therapeutics’s (OTLK) share price is $1.64, making it a Sell.

Outlook Therapeutics (OTLK) Pivot Points

Feb 22, 2025, 02:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.55
1.59
1.64
1.68
1.73
1.77
1.82
Fibonacci
1.59
1.62
1.64
1.68
1.71
1.73
1.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Outlook Therapeutics (OTLK) Moving Averages

Feb 22, 2025, 02:28 AM
Period
Simple
Exponential
MA5
1.75Sell
1.71Sell
MA10
1.73Sell
1.75Sell
MA20
1.83Sell
1.83Sell
MA50
1.85Sell
2.28Sell
MA100
3.46Sell
3.32Sell
MA200
5.46Sell
5.06Sell
Outlook Therapeutics’s (OTLK) 10-Day exponential moving average is 1.75, while Outlook Therapeutics’s (OTLK) share price is $1.64, making it a Sell.
Outlook Therapeutics’s (OTLK) 100-Day exponential moving average is 3.32, while Outlook Therapeutics’s (OTLK) share price is $1.64, making it a Sell.
Outlook Therapeutics’s (OTLK) stock price is $1.64 and Outlook Therapeutics’s (OTLK) 50-day simple moving average is 1.85, creating a Sell signal.
Outlook Therapeutics’s (OTLK) stock price is $1.64 and Outlook Therapeutics’s (OTLK) 100-day simple moving average is 3.46, creating a Sell signal.
Outlook Therapeutics’s (OTLK) stock price is $1.64 and Outlook Therapeutics’s (OTLK) 200-day simple moving average is 5.46, creating a Sell signal.

Outlook Therapeutics (OTLK) Technical Indicators

Feb 22, 2025, 02:28 AM
Name
Value
Implied Action
RSI (14)
36.96
Neutral
STOCH (9,6)
25.20
Neutral
STOCHRSI (14)
15.20
Buy
MACD (12,26)
-0.12
Sell
ADX (14)
15.32
Buy
Williams %R
-91.18
Buy
CCI (14)
-99.66
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
56.83
Neutral
ROC
-18.81
Sell
Outlook Therapeutics’s (OTLK) Relative Strength Index (RSI) is 36.96, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Trend Strength Indicator (ADX) is 15.32, creating a Buy signal.
Outlook Therapeutics’s (OTLK) Commodity Channel Index (CCI) is -99.66, creating a Neutral signal.
Outlook Therapeutics’s (OTLK) Price Rate of Change (ROC) is -18.81, creating a Sell signal.

FAQ

Is OTLK a Buy, Hold, or Sell?
Based on OTLK’s technical indicators, OTLK is a Strong Sell.
    What is OTLK’s RSI (14)?
    OTLK’s RSI (14) is 36.96, which suggests OTLK is a Neutral.
      What is OTLK’s MACD?
      OTLK’s MACD is -0.12, which suggests OTLK is a Sell.
        What is OTLK’s 5-day moving average?
        OTLK’s 5-day moving average is 1.75, which suggests OTLK is a Sell.
          What is OTLK’s 20-day moving average?
          OTLK 20-day moving average is 1.83, which suggests OTLK is a Sell.
            What is OTLK’s 50-day moving average?
            OTLK’s 50-day moving average is 1.85, which suggests OTLK is a Sell.
              What is OTLK’s 200-day moving average?
              OTLK’s 200-day moving average is 5.46, which suggests OTLK is a Sell.
                What is OTLK’s Williams % R (14)?
                OTLK’s Williams % R (14) is -91.18, which suggests OTLK is a Buy.
                  What is OTLK’s CCI (14)?
                  OTLK’s CCI (14) is -99.66, which suggests OTLK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis